Literature DB >> 21878973

Identifying R&D outliers.

Peter Tollman, Yves Morieux, Jeanine Kelly Murphy, Ulrik Schulze.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21878973     DOI： 10.1038/nrd3555

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

Review 1.  How to improve R&D productivity: the pharmaceutical industry's grand challenge.

Authors:  Steven M Paul; Daniel S Mytelka; Christopher T Dunwiddie; Charles C Persinger; Bernard H Munos; Stacy R Lindborg; Aaron L Schacht
Journal:  Nat Rev Drug Discov       Date:  2010-02-19       Impact factor: 84.694
  1 in total
  3 in total

Review 1.  Diagnosing the decline in pharmaceutical R&D efficiency.

Authors:  Jack W Scannell; Alex Blanckley; Helen Boldon; Brian Warrington
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

2.  R&D productivity: on the comeback trail.

Authors:  Ulrik Schulze; Mathias Baedeker; Yen Ting Chen; David Greber
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

3.  The importance of being profiled: improving drug candidate safety and efficacy using ion channel profiling.

Authors:  Gregory J Kaczorowski; Maria L Garcia; Jacob Bode; Stephen D Hess; Umesh A Patel
Journal:  Front Pharmacol       Date:  2011-12-13       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.